Skip to content

CROI: Married people should be primary target for HIV prevention in Uganda, national study shows

CROI: Kivexa and Truvada have similar efficacy and safety

South Africa: updated PMTCT guidelines still lag behind international standards, say experts

CROI: Symptom checklist may help rule out advanced HIV in infants

FDA approves generic atazanavir

Boehringer-Ingelheim begins trial of once-daily extended release nevirapine

CROI: Region of origin and gender significant in long-term changes in CD4 cell count during effective HIV therapy

CROI: Tetherin: a newly discovered host cell protein that inhibits HIV replication

Reckless HIV transmission case dismissed due to insufficient evidence (amended)